Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

Abstract

Although low-dose enoximone appears to be safe in patients with advanced HF, major clinical outcomes are not improved.